Our work extends from the laboratory to wide-scale community studies with a focus on diagnosis, prevention and treatment of diabetes and cardiovascular disease.
Biomarkers that highlight toxic fats in the liver.
NLRP1 Obesity and diabetes ‘sensor’ protein identified.
Imaging athletes’ hearts during exercise, not at rest.
Benefits for type 2 diabetes of interrupting prolonged sitting.
IL-1 The discovery that fat in obese people causes the release of a molecule called IL-1.
With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.
Find out more
